AHRAmerican Healthcare REIT, Inc.
American Healthcare REIT, Inc. (AHR) owns and operates healthcare real estate, generating income through rent and fees from tenants in hospitals, surgery centers, and other medical facilities. The next catalyst is Oct 16, 2026 — American Healthcare REIT Set News, which will test the company’s ability to execute its leadership strategy and maintain momentum after recent earnings.
- AHR’s revenue grew 11.2% YoY to $2.28B, with a net margin of 5.3% and free cash flow of $652.12M in the trailing twelve months.
- The company has $3.32B in shareholders’ equity and a diluted EPS of $0.16, reflecting a leveraged balance sheet.
- AHR’s leadership changes and strategic focus on enhancing its platform will be under scrutiny in the upcoming news release.
The schedule
- Fri16Oct
This event will likely involve a strategic update or announcement related to portfolio management, acquisitions, or dividend policy. It will test the issuer's ability to communicate value in a low-growth environment.
- Mon9Nov
This is a repeat of the Q3 2026 earnings print, which will test the issuer's ability to deliver consistent results amid macroeconomic headwinds. The outcome will be critical for investor confidence in the REIT's long-term strategy.
- Tue9Feb
This earnings print will test the issuer's ability to deliver results in a potentially more challenging macro environment. The outcome will be critical for assessing the REIT's resilience and long-term growth potential.
- Fri7May
This earnings print will test the issuer's ability to deliver results in a potentially more challenging macro environment. The outcome will be critical for assessing the REIT's resilience and long-term growth potential.
- Fri6Aug
This earnings print will test the issuer's ability to deliver results in a potentially more challenging macro environment. The outcome will be critical for assessing the REIT's resilience and long-term growth potential.
Past
- Fri7Aug
Actual outcome: Bear · $52.69 at outcome
AHR reported in-line earnings with no guidance changes, but the stock fell 7.1% likely due to broader market sentiment and lack of positive catalysts post-earnings. The price action suggests a bearish reaction despite the neutral results.
AHR reported in-line earnings with no guidance changes, but the stock fell 7.1% likely due to broader market sentiment and lack of positive catalysts post-earnings. The price action suggests a bearish reaction despite the neutral results.
- Fri8May
Actual outcome: Bull · $51.14 at outcome
American Healthcare REIT reported in-line Q1 2026 EPS but delivered double-digit same-store net operating income growth and increased its full-year 2026 guidance. The strong fundamental performance, driven by its Trilogy integrated senior health campus and senior housing operating portfolio, clearly aligned with the bull case expectations for solid rent coverage and occupancy, supporting the stock's push toward the bull target.
American Healthcare REIT reported in-line Q1 2026 EPS but delivered double-digit same-store net operating income growth and increased its full-year 2026 guidance. The strong fundamental performance, driven by its Trilogy integrated senior health campus and senior housing operating portfolio, clearly aligned with the bull case expectations for solid rent coverage and occupancy, supporting the stock's push toward the bull target.
- Wed18Mar
Actual outcome: Bear · $47.94 at outcome
The stock fell below the bear floor as the FOMC meeting and interest rate reassessment likely signaled a more restrictive policy environment, which typically pressures interest-rate-sensitive sectors like healthcare REITs. Despite the company declaring its quarterly distribution on the event date, the 8.8% price decline reflects broader market concerns and institutional repositioning away from the sector following the Fed's decision.
The stock fell below the bear floor as the FOMC meeting and interest rate reassessment likely signaled a more restrictive policy environment, which typically pressures interest-rate-sensitive sectors like healthcare REITs. Despite the company declaring its quarterly distribution on the event date, the 8.8% price decline reflects broader market concerns and institutional repositioning away from the sector following the Fed's decision.
- Fri27Feb
Actual outcome: Bull · $52.37 at outcome
AHR exceeded its bull target of $51.00, reaching $52.24 by the run date, despite a significant headline EPS miss of $0.06 versus the $0.46 estimate. The market's positive reaction was driven by the issuance of 2026 FFO/AFFO guidance that satisfied the high growth expectations required for the REIT's valuation. This forward-looking outlook and the stability of the core healthcare portfolio outweighed the earnings miss and recent institutional stake reductions.
AHR exceeded its bull target of $51.00, reaching $52.24 by the run date, despite a significant headline EPS miss of $0.06 versus the $0.46 estimate. The market's positive reaction was driven by the issuance of 2026 FFO/AFFO guidance that satisfied the high growth expectations required for the REIT's valuation. This forward-looking outlook and the stability of the core healthcare portfolio outweighed the earnings miss and recent institutional stake reductions.
